Metagenomic Next-Generation Sequencing as an Effective Diagnostic Tool for Talaromycosis in HIV-Negative Patients

Mycopathologia. 2024 Jul 10;189(4):63. doi: 10.1007/s11046-024-00866-x.

Abstract

The diagnosis of Talaromyces marneffei infection in HIV-negative patients remains challenging. There is an urgent need for rapid and convenient methods to diagnose this complicated disease. The aim of this study was to evaluate the diagnostic efficiency of metagenomic next-generation sequencing (mNGS) for talaromycosis in non-HIV-infected patients by comparing mNGS with traditional microbial culture. In total, 66 samples from 57 patients were analyzed via both mNGS and microbial culture. The ROC curve showed a sensitivity for mNGS of 97.22%, which was greater than that of microbial culture (61.11%). Samples from the respiratory tract, infectious skin lesions, and lymph nodes are recommended as routine samples for talaromycosis detection via mNGS. Furthermore, mNGS significantly reduced the diagnostic time compared to microbial culture. Overall, our study demonstrated that mNGS is a promising tool for rapid and accurate pathogenic detection in HIV-negative patients with talaromycosis.

Keywords: Talaromyces marneffei; Diagnostic method; Endemic mycosis; HIV-negative; Metagenomic next-generation sequencing.

Publication types

  • Evaluation Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Female
  • High-Throughput Nucleotide Sequencing* / methods
  • Humans
  • Male
  • Metagenomics* / methods
  • Middle Aged
  • Mycoses* / diagnosis
  • Mycoses* / microbiology
  • ROC Curve
  • Sensitivity and Specificity*
  • Talaromyces* / genetics
  • Talaromyces* / isolation & purification
  • Young Adult

Supplementary concepts

  • talaromycosis
  • Talaromyces marneffei